127 related articles for article (PubMed ID: 11565329)
1. [Converting enzyme inhibitors or AT1 receptor blockers].
Trevethan Cravioto S
Arch Cardiol Mex; 2001; 71 Suppl 1():S171-6. PubMed ID: 11565329
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
Johnston CI
Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
Feldman R
Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
[TBL] [Abstract][Full Text] [Related]
4. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
5. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
Weber MA
Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
7. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
8. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of arterial hypertension with angiotensin receptor blockers].
Nobre FL
Rev Port Cardiol; 1999 Apr; 18(4):407-12. PubMed ID: 10371849
[TBL] [Abstract][Full Text] [Related]
12. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
13. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
Baer JT; Sauer WH; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
[TBL] [Abstract][Full Text] [Related]
14. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
15. [Concurrence to ACE inhibitors? AT1 receptor blockers and hypertension].
Heemann U; Kribben A; Phillip T
Pharm Unserer Zeit; 2001; 30(4):309-12. PubMed ID: 11499256
[No Abstract] [Full Text] [Related]
16. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin-converting enzyme inhibitors and/or angiotensin II receptors antagonists in the treatment of arterial hypertension].
Silance PG
Rev Med Brux; 2003 Sep; 24(4):A253-6. PubMed ID: 14606289
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
